Last 7 days
-0.9%
Last 30 days
-6.0%
Last 90 days
-4.5%
Trailing 12 Months
7.2%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-16 | Ajer Jeffrey Robert | sold | -450,000 | 90.00 | -5,000 | evp, chief commercial officer |
2023-08-10 | FUCHS HENRY J | sold | -1,085,110 | 90.4259 | -12,000 | president, worldwide r&d |
2023-08-09 | Guyer Charles Greg | sold | -500,109 | 93.304 | -5,360 | evp, chief technical officer |
2023-08-08 | BIENAIME JEAN JACQUES | sold | -529,740 | 88.29 | -6,000 | chief executive officer |
2023-08-08 | Davis George Eric | sold | -983,662 | 89.4238 | -11,000 | evp, chief legal officer |
2023-08-07 | BIENAIME JEAN JACQUES | sold | -352,400 | 88.1 | -4,000 | chief executive officer |
2023-06-29 | Mueller Brian | sold (taxes) | -869,735 | 88.93 | -9,780 | evp, chief financial officer |
2023-05-23 | Dere Willard H | acquired | - | - | 4,190 | - |
2023-05-23 | MEIER RICHARD A | acquired | - | - | 4,190 | - |
2023-05-23 | Slamon Dennis | acquired | - | - | 4,190 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | reduced | -25.00 | -12,892 | 26,004 | -% |
2023-09-21 | Jefferies Group LLC | added | 794 | 1,644,580 | 1,846,290 | 0.01% |
2023-09-20 | BARCLAYS PLC | added | 65.83 | 74,627,000 | 230,678,000 | 0.15% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | unchanged | - | -68,640 | 563,420 | 0.48% |
2023-09-12 | Farther Finance Advisors, LLC | added | 309 | 2,831 | 3,901 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | new | - | 1,439,060 | 1,439,060 | 0.33% |
2023-08-28 | DT Investment Partners, LLC | unchanged | - | -1,844 | 20,559 | -% |
2023-08-24 | PERCEPTIVE ADVISORS LLC | reduced | -60.89 | -42,633,600 | 22,814,800 | 0.66% |
2023-08-24 | Alberta Investment Management Corp | added | 50.57 | 123,106 | 482,894 | -% |
2023-08-24 | Arlington Capital Management, Inc. | sold off | -100 | -2,801,480 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | dodge & cox | 7.7% | 14,383,663 | SC 13G/A | |
Feb 13, 2023 | capital research global investors | 3.0% | 5,651,001 | SC 13G/A | |
Feb 09, 2023 | primecap management co/ca/ | 9.46% | 17,580,859 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.34% | 17,365,080 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.2% | 15,206,690 | SC 13G/A | |
Mar 11, 2022 | blackrock inc. | 7.6% | 14,021,292 | SC 13G/A | |
Feb 14, 2022 | dodge & cox | 8.1% | 14,825,049 | SC 13G/A | |
Feb 10, 2022 | primecap management co/ca/ | 9.7% | 17,804,780 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.91% | 16,351,031 | SC 13G/A | |
Feb 08, 2022 | blackrock inc. | 7.6% | 14,021,292 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 17, 2023 | 4 | Insider Trading | |
Aug 16, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 11, 2023 | 4 | Insider Trading | |
Aug 10, 2023 | 4 | Insider Trading | |
Aug 10, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 09, 2023 | 4 | Insider Trading | |
Aug 09, 2023 | 4 | Insider Trading | |
Aug 09, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 08, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 08, 2023 | 144 | Notice of Insider Sale Intent |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 143.9B | 26.6B | 4.94% | 20.46% | 18.04 | 5.41 | 0.75% | 21.34% |
GILD | 94.2B | 27.4B | -1.73% | 23.33% | 17.17 | 3.44 | -0.48% | 32.56% |
MRNA | 37.4B | 10.7B | -12.34% | -18.02% | 30.97 | 3.51 | -53.67% | -91.41% |
BIIB | 37.3B | 10.0B | -2.41% | 31.83% | 14.01 | 3.74 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 11.2B | 1.7B | 6.64% | 14.01% | 63.44 | 6.69 | 29.01% | 1345.90% |
BBIO | 4.3B | - | -10.44% | 191.13% | -7.34 | 48.33 | 54.84% | -12.96% |
DNLI | 2.9B | - | -7.08% | -17.64% | -22.89 | 37.44 | 122.90% | 54.78% |
BEAM | 1.8B | 80.2M | 1.68% | -49.31% | -5.62 | 22.95 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.4B | 121.2M | -15.01% | -21.70% | -4.98 | 11.8 | -70.36% | -531.73% |
REPL | 941.3M | 15.3M | -22.34% | -0.87% | -5.18 | 61.48 | 1090.59% | -36.57% |
NVAX | 670.5M | 1.6B | -11.68% | -62.32% | -1.14 | 0.42 | 23.74% | 60.24% |
FATE | 199.0M | - | -23.19% | -90.40% | -0.94 | 1.45 | 116.83% | 16.61% |
SGMO | 118.0M | - | -12.12% | -85.84% | -0.59 | 0.49 | 113.96% | -15.19% |
VXRT | 107.9M | 2.1M | -9.82% | -66.03% | -1.07 | 52.51 | 487.70% | -8.66% |
IBIO | 3.7M | - | -11.16% | -96.28% | -0.05 | 3.21 | - | -129.46% |
1.7%
-1.4%
-2.1%
4.4%
65.4%
30%
18.5%
Y-axis is the maximum loss one would have experienced if Biomarin Pharmaceutical was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.8% | 2,235 | 2,173 | 2,096 | 2,008 | 1,912 | 1,880 | 1,846 | 1,849 | 1,917 | 1,844 | 1,860 | 1,863 | 1,847 | 1,805 | 1,704 | 1,603 | 1,533 | 1,519 | 1,491 | 1,496 | 1,439 |
Cost Of Revenue | 1.0% | 498 | 493 | 484 | 476 | 463 | 467 | 471 | 477 | 562 | 533 | 524 | 494 | 402 | 382 | 359 | 339 | 321 | 322 | 315 | 316 | 297 |
Costs and Expenses | 2.0% | 2,143 | 2,102 | 1,946 | 1,900 | 1,854 | 1,850 | 1,929 | 1,917 | 1,987 | 1,968 | 1,904 | 1,864 | 1,788 | 1,747 | 1,805 | 1,732 | 1,683 | 1,652 | 1,615 | 1,524 | 1,464 |
S&GA Expenses | 2.1% | 901 | 882 | 854 | 826 | 792 | 780 | 759 | 737 | 733 | 725 | 738 | 730 | 721 | 706 | 681 | 657 | 636 | 628 | 604 | 600 | 582 |
R&D Expenses | 2.9% | 680 | 661 | 650 | 638 | 638 | 641 | 629 | 624 | 614 | 635 | 628 | 644 | 670 | 674 | 715 | 718 | 706 | 696 | 696 | 690 | 682 |
EBITDA | -100.0% | - | 157 | 268 | 188 | 146 | 127 | 48.00 | 46.00 | 36.00 | 13.00 | 92.00 | 123 | 192 | 192 | 34.00 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.07* | 0.13* | 0.09* | 0.08* | 0.07* | 0.03* | 0.02* | 0.02* | 0.01* | 0.05* | 0.07* | 0.10* | 0.11* | 0.02* | - | - | - | - | - | - |
Interest Expenses | -0.7% | 16.00 | 16.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 16.00 | 22.00 | 26.00 | 29.00 | 31.00 | 25.00 | 24.00 | 23.00 | 24.00 | 33.00 | 39.00 | 44.00 | 48.00 | 46.00 |
Earnings Before Taxes | 49.8% | 108 | 72.00 | 150 | 101 | 56.00 | 36.00 | -75.35 | -55.64 | -70.69 | -127 | -49.00 | -11.92 | 59.00 | 59.00 | -94.81 | -128 | -157 | -144 | -142 | -44.80 | -46.00 |
EBT Margin | -100.0% | - | 0.03* | 0.07* | 0.05* | 0.03* | 0.02* | -0.04* | -0.03* | -0.03* | -0.07* | -0.02* | -0.01* | 0.03* | 0.03* | -0.06* | - | - | - | - | - | - |
Net Income | 39.6% | 100 | 72.00 | 142 | 84.00 | 54.00 | 39.00 | -64.08 | 11.00 | 832 | 790 | 854 | 852 | 122 | 114 | -23.85 | -42.52 | -110 | -89.53 | -77.21 | -124 | -124 |
Net Income Margin | -100.0% | - | 0.03* | 0.07* | 0.04* | 0.03* | 0.02* | -0.03* | 0.01* | 0.44* | 0.43* | 0.46* | 0.46* | 0.07* | 0.06* | -0.01* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 31.00 | 55.00 | 66.00 | 16.00 | 47.00 | 209 | 182 | 173 | 115 | -28.95 | 22.00 | -10.34 | -68.89 | -96.76 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 2.0% | 6,563 | 6,434 | 6,375 | 6,264 | 6,146 | 6,063 | 6,005 | 5,977 | 5,898 | 5,805 | 5,848 | 6,158 | 5,302 | 4,723 | 4,690 | 4,558 | 4,393 | 4,435 | 4,427 | 4,695 | 4,625 |
Current Assets | 3.8% | 2,950 | 2,842 | 2,751 | 2,683 | 2,518 | 2,394 | 2,274 | 2,312 | 2,358 | 2,289 | 2,342 | 2,739 | 2,648 | 2,116 | 1,942 | 1,859 | 1,807 | 1,917 | 2,056 | 2,408 | 2,280 |
Cash Equivalents | 19.7% | 694 | 580 | 725 | 762 | 620 | 605 | 587 | 617 | 642 | 667 | 649 | 1,016 | 819 | 477 | 437 | 423 | 308 | 364 | 494 | 882 | 427 |
Inventory | 6.2% | 976 | 919 | 894 | 839 | 802 | 786 | 777 | 749 | 711 | 714 | 699 | 701 | 744 | 706 | 680 | 609 | 579 | 535 | 531 | 508 | 473 |
Net PPE | -0.1% | 1,067 | 1,068 | 1,073 | 1,052 | 1,049 | 1,040 | 1,035 | 1,025 | 1,027 | 1,022 | 1,032 | 1,015 | 1,011 | 1,010 | 1,011 | 969 | 963 | 952 | 949 | 924 | 900 |
Goodwill | 0% | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 197 | 197 | 197 | 197 | 197 | 197 | 197 |
Liabilities | 0.3% | 1,780 | 1,775 | 1,772 | 1,696 | 1,641 | 1,671 | 1,739 | 1,711 | 1,657 | 1,643 | 1,742 | 2,104 | 2,065 | 1,483 | 1,568 | 1,484 | 1,432 | 1,499 | 1,459 | 1,780 | 1,740 |
Current Liabilities | -0.2% | 597 | 598 | 589 | 521 | 465 | 490 | 546 | 515 | 443 | 430 | 493 | 855 | 813 | 820 | 933 | 494 | 439 | 501 | 523 | 839 | 805 |
Shareholder's Equity | 2.7% | 4,783 | 4,659 | 4,603 | 4,569 | 4,500 | 4,386 | 4,266 | 4,261 | 4,237 | 4,162 | 4,101 | 4,054 | 3,237 | 3,240 | 3,122 | 3,074 | 2,961 | 2,937 | 2,968 | 2,915 | 2,885 |
Retained Earnings | 7.6% | -682 | -738 | -789 | -788 | -777 | -804 | -930 | -867 | -831 | -844 | -861 | -883 | -1,668 | -1,639 | -1,720 | -1,735 | -1,790 | -1,753 | -1,694 | -1,690 | -1,677 |
Additional Paid-In Capital | 1.4% | 5,494 | 5,418 | 5,405 | 5,336 | 5,273 | 5,206 | 5,192 | 5,134 | 5,084 | 5,011 | 4,993 | 4,938 | 4,886 | 4,855 | 4,833 | 4,783 | 4,744 | 4,683 | 4,670 | 4,621 | 4,577 |
Accumulated Depreciation | 2.8% | 829 | 807 | 802 | 782 | 762 | 741 | 721 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 0.3% | 188 | 188 | 186 | 186 | 185 | 184 | 184 | 183 | 183 | 182 | 182 | 181 | 181 | 180 | 180 | 179 | 179 | 178 | 178 | 177 | 177 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 9.4% | 161 | 147 | 176 | 180 | 119 | 146 | 305 | 280 | 269 | 214 | 85.00 | 156 | 140 | 88.00 | 48.00 | 40.00 | 17.00 | 8.00 | 20.00 | -14.55 | -23.46 |
Share Based Compensation | 1.5% | 205 | 202 | 196 | 193 | 188 | 196 | 197 | 201 | 202 | 192 | 190 | 180 | 169 | 164 | 160 | 158 | 156 | 155 | 149 | 146 | 145 |
Cashflow From Investing | 43.0% | -78.59 | -137 | -20.03 | -20.74 | -117 | -207 | -366 | -299 | -73.32 | -201 | -53.62 | -113 | -171 | 97.00 | -31.03 | -53.09 | 301 | 286 | 264 | 475 | -357 |
Cashflow From Financing | 69.6% | -10.37 | -34.11 | -18.65 | -15.12 | -23.69 | -0.96 | -0.05 | -380 | -376 | 176 | 181 | 551 | 546 | -69.36 | -74.67 | -445 | -437 | -403 | -388 | -8.55 | 468 |
Buy Backs | - | - | - | - | - | - | - | - | - | - | - | 50.00 | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
REVENUES: | ||||
Total revenues | $ 595,275 | $ 533,798 | $ 1,191,690 | $ 1,053,157 |
OPERATING EXPENSES: | ||||
Cost of sales | 128,082 | 123,126 | 254,631 | 240,091 |
Research and development | 177,363 | 158,190 | 349,209 | 319,026 |
Selling, general and administrative | 215,336 | 196,835 | 438,339 | 391,454 |
Intangible asset amortization and contingent consideration | 15,624 | 16,495 | 31,294 | 34,107 |
Gain on sale of nonfinancial assets, net | 0 | 0 | 0 | (108,000) |
Total operating expenses | 536,405 | 494,646 | 1,073,473 | 876,678 |
INCOME FROM OPERATIONS | 58,870 | 39,152 | 118,217 | 176,479 |
Interest income | 12,612 | 2,505 | 24,555 | 4,325 |
Interest expense | (3,755) | (3,859) | (7,458) | (7,665) |
Other income (expense), net | 3,083 | (2,947) | (7,747) | (4,101) |
INCOME BEFORE INCOME TAXES | 70,810 | 34,851 | 127,567 | 169,038 |
Provision for income taxes | 14,770 | 7,187 | 20,675 | 20,576 |
NET INCOME | $ 56,040 | $ 27,664 | $ 106,892 | $ 148,462 |
Earnings per share, basic (in dollars per share) | $ 0.30 | $ 0.15 | $ 0.57 | $ 0.80 |
Earnings per share, diluted (in dollars per share) | $ 0.29 | $ 0.15 | $ 0.56 | $ 0.79 |
Weighted average common shares outstanding, basic (in shares) | 187,948 | 185,254 | 187,311 | 184,710 |
Weighted average common shares outstanding, diluted (in shares) | 194,998 | 187,448 | 194,756 | 191,096 |
COMPREHENSIVE INCOME | $ 48,145 | $ 47,013 | $ 92,142 | $ 152,502 |
Net product revenues | ||||
REVENUES: | ||||
Total revenues | 584,698 | 517,660 | 1,171,124 | 1,023,185 |
Royalty and other revenues | ||||
REVENUES: | ||||
Total revenues | $ 10,577 | $ 16,138 | $ 20,566 | $ 29,972 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 | [1] | ||||
---|---|---|---|---|---|---|---|
Current assets: | |||||||
Cash and cash equivalents | $ 694,381 | $ 724,531 | |||||
Short-term investments | 476,577 | 567,006 | |||||
Accounts receivable, net | 610,222 | 461,316 | |||||
Inventory | 975,546 | 894,083 | |||||
Other current assets | 193,391 | 104,521 | |||||
Total current assets | 2,950,117 | 2,751,457 | |||||
Noncurrent assets: | |||||||
Long-term investments | 385,777 | 333,835 | |||||
Property, plant and equipment, net | 1,067,278 | 1,073,366 | |||||
Intangible assets, net | 310,343 | 338,569 | |||||
Goodwill | 196,199 | 196,199 | |||||
Deferred tax assets | 1,509,290 | 1,505,412 | |||||
Other assets | 144,168 | 176,236 | |||||
Total assets | 6,563,172 | 6,375,074 | |||||
Current liabilities: | |||||||
Accounts payable and accrued liabilities | 597,231 | 572,959 | |||||
Short-term contingent consideration | 0 | 15,925 | |||||
Total current liabilities | 597,231 | 588,884 | |||||
Noncurrent liabilities: | |||||||
Long-term convertible debt, net | 1,084,994 | 1,083,019 | |||||
Other long-term liabilities | 98,120 | 100,015 | |||||
Total liabilities | 1,780,345 | 1,771,918 | |||||
Stockholders’ equity: | |||||||
Common stock, $0.001 par value: 500,000,000 shares authorized; 188,151,695 and 186,250,719 shares issued and outstanding, respectively | 188 | 186 | |||||
Additional paid-in capital | 5,493,956 | 5,404,895 | |||||
Company common stock held by the Nonqualified Deferred Compensation Plan | (10,393) | (8,859) | |||||
Accumulated other comprehensive loss | (18,617) | (3,867) | |||||
Accumulated deficit | (682,307) | (789,199) | |||||
Total stockholders’ equity | 4,782,827 | 4,603,156 | [2] | ||||
Total liabilities and stockholders’ equity | $ 6,563,172 | $ 6,375,074 | |||||
|